Conference abstract · 18 Jul 2016
Conference abstract
Experimental methods to study interplay of dissolution, solubility and permeability in formulation development
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Development strategy for insoluble compounds requires not only measurements of the solubility enhancement from formulations but also the assessment for the effect formulations having on permeability. An introduced dissolution-permeability (μFLUX) measurement platform allows simultaneous monitoring for both effects enabling in-vitro setup for early in-vivo predictive formulations testing. Ability to measure concentration of free (solubilized) drug in situ is critical necessity in formulation research because any offline solution handling can disturb quasi-stable (kinetic) phase that low soluble compounds often form in the presence of excipients. Case studies involving 2 different detection techniques based on fiber-optic UV measurements and potentiometric free drug sensors (FDS) will be presented. These case studies will highlight: Combining dissolution and permeability assays for better formulation design, understanding the food effect on bioavailability and more realistic IVIVC; studying if solubility enhancement in the biorelevant media leads to the same gain in the absorption and bioavailability; real time concentration monitoring of free drug in the presence of lipid passed formulations, nanoparticles and binding proteins; monitoring in real time the free API fraction released from nanoparticles and predicting absorption enhancement from nanoparticle formulations and; developing predictive in-vitro method to monitor powder/formulation dissolution and concomitant precipitation processes in dynamically changing biorelevant media.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 30 Jun 2016
The solubility-permeability interplay and formulation development of low-solubility drugs
Conference abstract · 26 Jun 2017
Developing better formulations for oral lipophilic drugs by accounting for both the solubility and the intestinal permeability
Commentary · 18 Feb 2022
The Solubility Permeability Interplay and Implications in Manufacture Design and Improvement for Poor Soluble Drugs
Conference abstract · 26 Oct 2015
QbD approach for the development and optimization of HPLC method for the simultaneous estimation of four component cream formulation: Application to permeability study
More from this journal
The newest in Pharmaceutica Analytica Acta.
Article · 16 Sep 2026
The Fc Domains in the Monoclonal Antibody and Fusion Protein Significantly Boost the Biocomposite Suspension's Power to Combat Harmful Microorganisms, Enhance Drug Delivery, and Improve Protein Stability
Article · 26 Jun 2026
Green Pathways in Drug Quality Assessment: The Growing Role of Sustainable Pharmaceutical Analytics
Article · 26 Jun 2026
Advanced Single-Cell Signal Analysis: The Role of Ghost Cytometry in Cell Therapy Characterization
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Balint Sinko”

